Effect / research focus
Is being studied clinically for body weight, metabolism, and cardiovascular and kidney outcomes.
Back to the peptide atlas
Metabolism & GLP-1PeptideIn clinical research
Retatrutide
GIP, GLP-1 and glucagon receptor agonist
Also known as: LY3437943 · GLP-1/GIP/glucagon
How communities discuss it
Discussed in online communities in relation to the research focus described above. Anecdotes are not evidence of efficacy and are not use instructions.
Community reports are anecdotes, not evidence of efficacy or safety.
Why there is no mixing guide here
Reconstitution depends on the exact approved product, its official label and medical supervision. With unapproved substances, identity, concentration, sterility and stability are often unknown. A universal step-by-step guide would therefore be unsafe.
Primary sources
The linked regulator and trial-register sources support the current status summary.